Evolving Role of HER2-Targeted Therapy in Breast Cancer

Описание к видео Evolving Role of HER2-Targeted Therapy in Breast Cancer

Drs Stephanie Graff and Erika P. Hamilton discuss the evolution of HER2-targeted therapies in breast cancer, beginning with a conversation around the development of trastuzumab and pertuzumab for appropriate patients and then discuss the more recent rationale behind treating patients with T-DM1.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Комментарии

Информация по комментариям в разработке